Differential effects of betamethasone on the fetus between morning and afternoon recordings

References

• Crowley P A. Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995; 173: 322–335
   PubMed Web of Science ®Google Scholar
• Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2000; 2, CD000065
   Google Scholar
• Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3, CD004454
   Web of Science ®Google Scholar
• Dessens A B, Haas H S, Koppe J G. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics 2000; 105: E77
   PubMed Web of Science ®Google Scholar
• Dalziel S R, Lim V K, Lambert A, McCarthy D, Parag V, Rodgers A, Harding J E. Antenatal exposure to betamethasone: Psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 2005; 331: 665
   PubMed Web of Science ®Google Scholar
• Dalziel S R, Walker N K, Parag V, Mantell C, Rea H H, Rodgers A, Harding J E. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005; 365: 1856–1862
   PubMed Web of Science ®Google Scholar
• Mulder E J, Derks J B, Zonneveld M F, Bruinse H W, Visser G H. Transient reduction in fetal activity and heart rate variation after maternal betamethasone administration. Early Hum Dev 1994; 36: 49–60
   PubMed Web of Science ®Google Scholar
• Derks J B, Mulder E J, Visser G H. The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol 1995; 102: 40–46
   PubMedGoogle Scholar
• Mulder E J, Derks J B, Visser G H. Antenatal corticosteroid therapy and fetal behaviour: A randomised study of the effects of betamethasone and dexamethasone. Br J Obstet Gynaecol 1997; 104: 1239–1247
   PubMedGoogle Scholar
• Katz M, Meizner I, Holcberg G, Mazor M, Hagay Z J, Insler V. Reduction or cessation of fetal movements after administration of steroids for enhancement of lung maturation. I. Clinical evaluation. Isr J Med Sci 1988; 24: 5–9
   PubMedGoogle Scholar
• Dawes G S, Serra-Serra V, Moulden M, Redman C W. Dexamethasone and fetal heart rate variation. Br J Obstet Gynaecol 1994; 101: 675–679
   PubMedGoogle Scholar
• Magee L A, Dawes G S, Moulden M, Redman C W. A randomised controlled comparison of betamethasone with dexamethasone: Effects on the antenatal fetal heart rate. Br J Obstet Gynaecol 1997; 104: 1233–1238
   PubMedGoogle Scholar
• Senat M V, Minoui S, Multon O, Fernandez H, Frydman R, Ville Y. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: A randomised study. Br J Obstet Gynaecol 1998; 105: 749–755
   Google Scholar
• Rotmensch S, Liberati M, Celentano C, Efrat Z, Bar-Hava I, Kovo M, Golan A, Moravski G, Ben-Rafael Z. The effect of betamethasone on fetal biophysical activities and Doppler velocimetry of umbilical and middle cerebral arteries. Acta Obstet Gynecol Scand 1999; 78: 768–773
   PubMed Web of Science ®Google Scholar
• Kelly M K, Schneider E P, Petrikovsky B M, Lesser M L. Effect of antenatal steroid administration on the fetal biophysical profile. J Clin Ultrasound 2000; 28: 224–226
   PubMed Web of Science ®Google Scholar
• Mushkat Y, Ascher-Landsberg J, Keidar R, Carmon E, Pauzner D, David M P. The effect of betamethasone versus dexamethasone on fetal biophysical parameters. Eur J Obstet Gynecol Reprod Biol 2001; 97: 50–52
   Google Scholar
• de Vries J I, Visser G H, Mulder E J, Prechtl H F. Diurnal and other variations in fetal movement and heart rate patterns at 20–22 weeks. Early Hum Dev 1987; 15: 333–348
   PubMedGoogle Scholar
• Visser G H, Goodman J D, Levine D H, Dawes G S. Diurnal and other cyclic variations in human fetal heart rate near term. Am J Obstet Gynecol 1982; 142: 535–544
   PubMed Web of Science ®Google Scholar
• Patrick J, Campbell K, Carmichael L, Natale R, Richardson B. Patterns of gross fetal body movements over 24-hour observation intervals during the last 10 weeks of pregnancy. Am J Obstet Gynecol 1982; 142: 363–371
   PubMed Web of Science ®Google Scholar
• Patrick J, Campbell K, Carmichael L, Natale R, Richardson B. Patterns of human fetal breathing during the last 10 weeks of pregnancy. Obstet Gynecol 1980; 56: 24–30
   PubMed Web of Science ®Google Scholar
• Koenen S V, Mulder E J, Wijnberger L D, Visser G H. Transient loss of the diurnal rhythms of fetal movements, heart rate, and its variation after maternal betamethasone administration. Pediatr Res 2005; 57: 662–666
   PubMed Web of Science ®Google Scholar
• Dawes G S, Moulden M, Redman C W. System 8000: Computerized antenatal FHR analysis. J Perinat Med 1991; 19: 47–51
   PubMed Web of Science ®Google Scholar
• Mulder E J, O'Brien M J, Lems Y L, Visser G H, Prechtl H F. Body and breathing movements in near-term fetuses and newborn infants of type-1 diabetic women. Early Hum Dev 1990; 24: 131–152
   PubMed Web of Science ®Google Scholar
• Lunshof S, Boer K, Wolf H, van Hoffen G, Bayram N, Mirmiran M. Fetal and maternal diurnal rhythms during the third trimester of normal pregnancy: Outcomes of computerized analysis of continuous twenty-four-hour fetal heart rate recordings. Am J Obstet Gynecol 1998; 178: 247–254
   PubMed Web of Science ®Google Scholar
• Patrick J, Campbell K, Carmichael L, Probert C. Influence of maternal heart rate and gross fetal body movements on the daily pattern of fetal heart rate near term. Am J Obstet Gynecol 1982; 144: 533–538
   PubMed Web of Science ®Google Scholar
• Moise A A, Wearden M E, Kozinetz C A, Gest A L, Welty S E, Hansen T N. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics 1995; 95: 845–850
   PubMed Web of Science ®Google Scholar
• Derks J B, Giussani D A, Jenkins S L, Wentworth R A, Visser G H, Padbury J F, Nathanielsz P W. A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol 1997; 499(Pt 1)217–226
   Google Scholar
• Koenen S V, Mecenas C A, Smith G S, Jenkins S, Nathanielsz P W. Effects of maternal betamethasone administration on fetal and maternal blood pressure and heart rate in the baboon at 0.7 of gestation. Am J Obstet Gynecol 2002; 186: 812–817
   PubMed Web of Science ®Google Scholar
• Lunshof M S, Boer K, Wolf H, Koppen S, Velderman J K, Mulder E J. Short-term (0–48 h) effects of maternal betamethasone administration on fetal heart rate and its variability. Pediatr Res 2005; 57: 545–549
   PubMed Web of Science ®Google Scholar
• Ullian M E. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 1999; 41: 55–64
   PubMed Web of Science ®Google Scholar
• Nijhuis I J, ten Hof J, Mulder E J, Nijhuis J G, Narayan H, Taylor D J, Visser G H. Fetal heart rate in relation to its variation in normal and growth retarded fetuses. Eur J Obstet Gynecol Reprod Biol 2000; 89: 27–33
   PubMed Web of Science ®Google Scholar
• Ralph M R, Foster R G, Davis F C, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990; 247: 975–978
   PubMed Web of Science ®Google Scholar
• Rietveld W J. The central control and ontogeny of circadian rhythmicity. Eur J Morphol 1990; 28: 301–307
   PubMedGoogle Scholar
• Rosenfeld P, van Eekelen J A, Levine S, de Kloet E R. Ontogeny of corticosteroid receptors in the brain. Cell Mol Neurobiol 1993; 13: 295–319
   PubMed Web of Science ®Google Scholar
• Dickmeis T, Lahiri K, Nica G, Vallone D, Santoriello C, Neumann C J, Hammerschmidt M, Foulkes N S. Glucocorticoids play a key role in circadian cell cycle rhythms. PLoS Biol 2007; 5: e78
   PubMed Web of Science ®Google Scholar
• Ashwood P J, Crowther C A, Willson K J, Haslam R R, Kennaway D J, Hiller J E, Robinson J S. Neonatal adrenal function after repeat dose prenatal corticosteroids: A randomized controlled trial. Am J Obstet Gynecol 2006; 194: 861–867
   PubMed Web of Science ®Google Scholar
• Patrick J, Challis J, Campbell K, Carmichael L, Natale R, Richardson B. Circadian rhythms in maternal plasma cortisol and estriol concentrations at 30 to 31, 34 to 35, and 38 to 39 weeks' gestational age. Am J Obstet Gynecol 1980; 136: 325–334
   PubMed Web of Science ®Google Scholar
• Challis J, Patrick J, Richardson B, Tevaarwerk G. Loss of diurnal rhythm in plasma estrone, estradiol, and estriol in women treated with synthetic glucocorticoids at 34 to 35 weeks' gestation. Am J Obstet Gynecol 1981; 139: 338–343
   Google Scholar
• Arduini D, Rizzo G, Parlati E, Giorlandino C, Valensise H, Dell'Acqua S, Romanini C. Modifications of ultradian and circadian rhythms of fetal heart rate after fetal–maternal adrenal gland suppression: A double blind study. Prenat Diagn 1986; 6: 409–417
   PubMed Web of Science ®Google Scholar
• Helal K J, Gordon M C, Lightner C R, Barth W WH, Jr. Adrenal suppression induced by betamethasone in women at risk for premature delivery. Obstet Gynecol 2000; 96: 287–290
   PubMed Web of Science ®Google Scholar